nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—ABCG2—Glyburide—gestational diabetes	0.339	0.419	CbGbCtD
Dabrafenib—SLC22A6—Glyburide—gestational diabetes	0.275	0.339	CbGbCtD
Dabrafenib—ABCB1—Glyburide—gestational diabetes	0.122	0.151	CbGbCtD
Dabrafenib—CYP3A4—Glyburide—gestational diabetes	0.0733	0.0905	CbGbCtD
Dabrafenib—NEK11—uterus—gestational diabetes	0.0116	0.12	CbGeAlD
Dabrafenib—LIMK1—adipose tissue—gestational diabetes	0.00809	0.0843	CbGeAlD
Dabrafenib—LIMK1—vagina—gestational diabetes	0.00673	0.0701	CbGeAlD
Dabrafenib—SIK1—islet of Langerhans—gestational diabetes	0.00656	0.0684	CbGeAlD
Dabrafenib—Nephropathy—Glyburide—gestational diabetes	0.00643	0.138	CcSEcCtD
Dabrafenib—RAF1—islet of Langerhans—gestational diabetes	0.00522	0.0544	CbGeAlD
Dabrafenib—BRAF—uterus—gestational diabetes	0.00511	0.0533	CbGeAlD
Dabrafenib—RAF1—embryo—gestational diabetes	0.00505	0.0526	CbGeAlD
Dabrafenib—BRAF—adipose tissue—gestational diabetes	0.005	0.0521	CbGeAlD
Dabrafenib—SIK1—uterus—gestational diabetes	0.00428	0.0446	CbGeAlD
Dabrafenib—SIK1—adipose tissue—gestational diabetes	0.00419	0.0436	CbGeAlD
Dabrafenib—BRAF—vagina—gestational diabetes	0.00416	0.0433	CbGeAlD
Dabrafenib—SLCO1B3—vagina—gestational diabetes	0.00358	0.0373	CbGeAlD
Dabrafenib—RAF1—Nongenotropic Androgen signaling—SHBG—gestational diabetes	0.0035	0.0728	CbGpPWpGaD
Dabrafenib—RAF1—uterus—gestational diabetes	0.00341	0.0355	CbGeAlD
Dabrafenib—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00337	0.0723	CcSEcCtD
Dabrafenib—RAF1—adipose tissue—gestational diabetes	0.00333	0.0347	CbGeAlD
Dabrafenib—SIK1—head—gestational diabetes	0.00321	0.0335	CbGeAlD
Dabrafenib—RAF1—vagina—gestational diabetes	0.00277	0.0289	CbGeAlD
Dabrafenib—RAF1—Signaling by Leptin—LEPR—gestational diabetes	0.00268	0.0557	CbGpPWpGaD
Dabrafenib—RAF1—head—gestational diabetes	0.00256	0.0267	CbGeAlD
Dabrafenib—Renal failure acute—Glyburide—gestational diabetes	0.00241	0.0517	CcSEcCtD
Dabrafenib—Dermatitis bullous—Glyburide—gestational diabetes	0.00233	0.0499	CcSEcCtD
Dabrafenib—Hyponatraemia—Glyburide—gestational diabetes	0.00223	0.0479	CcSEcCtD
Dabrafenib—SIK1—Circadian rythm related genes—MTNR1B—gestational diabetes	0.00212	0.0441	CbGpPWpGaD
Dabrafenib—Pancreatitis—Glyburide—gestational diabetes	0.00188	0.0404	CcSEcCtD
Dabrafenib—SIK1—Circadian rythm related genes—NAMPT—gestational diabetes	0.00186	0.0385	CbGpPWpGaD
Dabrafenib—SIK1—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.00152	0.0315	CbGpPWpGaD
Dabrafenib—SLC22A8—head—gestational diabetes	0.00149	0.0155	CbGeAlD
Dabrafenib—Eye disorder—Glyburide—gestational diabetes	0.00144	0.0309	CcSEcCtD
Dabrafenib—ABCG2—uterus—gestational diabetes	0.00141	0.0147	CbGeAlD
Dabrafenib—ABCG2—adipose tissue—gestational diabetes	0.00138	0.0144	CbGeAlD
Dabrafenib—Alopecia—Glyburide—gestational diabetes	0.00136	0.0292	CcSEcCtD
Dabrafenib—Erythema—Glyburide—gestational diabetes	0.00134	0.0287	CcSEcCtD
Dabrafenib—Malnutrition—Glyburide—gestational diabetes	0.00134	0.0287	CcSEcCtD
Dabrafenib—RAF1—FSH signaling pathway—CYP19A1—gestational diabetes	0.00131	0.0271	CbGpPWpGaD
Dabrafenib—Vision blurred—Glyburide—gestational diabetes	0.00126	0.0271	CcSEcCtD
Dabrafenib—Anaemia—Glyburide—gestational diabetes	0.00124	0.0266	CcSEcCtD
Dabrafenib—Leukopenia—Glyburide—gestational diabetes	0.0012	0.0257	CcSEcCtD
Dabrafenib—CYP2C8—vagina—gestational diabetes	0.00118	0.0123	CbGeAlD
Dabrafenib—RAF1—Leptin signaling pathway—LEPR—gestational diabetes	0.00115	0.0239	CbGpPWpGaD
Dabrafenib—ABCG2—vagina—gestational diabetes	0.00115	0.0119	CbGeAlD
Dabrafenib—Arthralgia—Glyburide—gestational diabetes	0.00114	0.0245	CcSEcCtD
Dabrafenib—Myalgia—Glyburide—gestational diabetes	0.00114	0.0245	CcSEcCtD
Dabrafenib—RAF1—Nongenotropic Androgen signaling—AR—gestational diabetes	0.00114	0.0236	CbGpPWpGaD
Dabrafenib—Oedema—Glyburide—gestational diabetes	0.00109	0.0235	CcSEcCtD
Dabrafenib—Nervous system disorder—Glyburide—gestational diabetes	0.00107	0.023	CcSEcCtD
Dabrafenib—Thrombocytopenia—Glyburide—gestational diabetes	0.00107	0.023	CcSEcCtD
Dabrafenib—ABCB1—islet of Langerhans—gestational diabetes	0.00107	0.0111	CbGeAlD
Dabrafenib—Hyperhidrosis—Glyburide—gestational diabetes	0.00106	0.0227	CcSEcCtD
Dabrafenib—ABCB1—embryo—gestational diabetes	0.00103	0.0107	CbGeAlD
Dabrafenib—Hypotension—Glyburide—gestational diabetes	0.00102	0.0219	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000995	0.0214	CcSEcCtD
Dabrafenib—BRAF—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000955	0.0198	CbGpPWpGaD
Dabrafenib—Decreased appetite—Glyburide—gestational diabetes	0.00095	0.0204	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000943	0.0203	CcSEcCtD
Dabrafenib—SIK1—Circadian rythm related genes—LEP—gestational diabetes	0.000943	0.0196	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Leptin—LEP—gestational diabetes	0.000942	0.0196	CbGpPWpGaD
Dabrafenib—Gastrointestinal pain—Glyburide—gestational diabetes	0.000893	0.0192	CcSEcCtD
Dabrafenib—Abdominal pain—Glyburide—gestational diabetes	0.000864	0.0185	CcSEcCtD
Dabrafenib—Hypersensitivity—Glyburide—gestational diabetes	0.000805	0.0173	CcSEcCtD
Dabrafenib—Asthenia—Glyburide—gestational diabetes	0.000784	0.0168	CcSEcCtD
Dabrafenib—Pruritus—Glyburide—gestational diabetes	0.000773	0.0166	CcSEcCtD
Dabrafenib—ABCG2—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000762	0.0158	CbGpPWpGaD
Dabrafenib—Diarrhoea—Glyburide—gestational diabetes	0.000748	0.0161	CcSEcCtD
Dabrafenib—BRAF—Negative regulation of FGFR signaling—FGF2—gestational diabetes	0.000732	0.0152	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—GLS2—gestational diabetes	0.000732	0.0152	CbGpPWpGaD
Dabrafenib—ABCB1—uterus—gestational diabetes	0.000695	0.00724	CbGeAlD
Dabrafenib—Vomiting—Glyburide—gestational diabetes	0.000695	0.0149	CcSEcCtD
Dabrafenib—Rash—Glyburide—gestational diabetes	0.000689	0.0148	CcSEcCtD
Dabrafenib—Dermatitis—Glyburide—gestational diabetes	0.000688	0.0148	CcSEcCtD
Dabrafenib—Headache—Glyburide—gestational diabetes	0.000684	0.0147	CcSEcCtD
Dabrafenib—ABCB1—adipose tissue—gestational diabetes	0.000679	0.00708	CbGeAlD
Dabrafenib—LIMK1—Caspase Cascade in Apoptosis—TNF—gestational diabetes	0.000672	0.014	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000661	0.0137	CbGpPWpGaD
Dabrafenib—Nausea—Glyburide—gestational diabetes	0.000649	0.0139	CcSEcCtD
Dabrafenib—BRAF—MAPK Signaling Pathway—GCK—gestational diabetes	0.000598	0.0124	CbGpPWpGaD
Dabrafenib—ABCB1—vagina—gestational diabetes	0.000565	0.00589	CbGeAlD
Dabrafenib—ABCB1—head—gestational diabetes	0.000522	0.00544	CbGeAlD
Dabrafenib—LIMK1—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000512	0.0106	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—GLS2—gestational diabetes	0.000506	0.0105	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—GCK—gestational diabetes	0.000505	0.0105	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—MBL2—gestational diabetes	0.000496	0.0103	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000476	0.00989	CbGpPWpGaD
Dabrafenib—RAF1—FRS2-mediated cascade—FGF2—gestational diabetes	0.00047	0.00975	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000463	0.00962	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.000462	0.00959	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—ADIPOQ—gestational diabetes	0.000416	0.00863	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—GCK—gestational diabetes	0.000414	0.00859	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000412	0.00856	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000409	0.00849	CbGpPWpGaD
Dabrafenib—RAF1—Leptin signaling pathway—LEP—gestational diabetes	0.000403	0.00838	CbGpPWpGaD
Dabrafenib—RAF1—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.000393	0.00816	CbGpPWpGaD
Dabrafenib—ABCG2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.00039	0.0081	CbGpPWpGaD
Dabrafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000373	0.00775	CbGpPWpGaD
Dabrafenib—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000368	0.00765	CbGpPWpGaD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000362	0.00752	CbGpPWpGaD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000303	0.00628	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000302	0.00627	CbGpPWpGaD
Dabrafenib—BRAF—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000299	0.00621	CbGpPWpGaD
Dabrafenib—RAF1—TWEAK Signaling Pathway—TNF—gestational diabetes	0.000297	0.00616	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—MBL2—gestational diabetes	0.000289	0.006	CbGpPWpGaD
Dabrafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.00028	0.00581	CbGpPWpGaD
Dabrafenib—RAF1—IRS-mediated signalling—FGF2—gestational diabetes	0.000277	0.00576	CbGpPWpGaD
Dabrafenib—RAF1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000276	0.00573	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000275	0.00571	CbGpPWpGaD
Dabrafenib—RAF1—IRS-related events—FGF2—gestational diabetes	0.00027	0.0056	CbGpPWpGaD
Dabrafenib—RAF1—IRS-related events triggered by IGF1R—FGF2—gestational diabetes	0.000267	0.00555	CbGpPWpGaD
Dabrafenib—RAF1—Ceramide signaling pathway—TNF—gestational diabetes	0.000267	0.00554	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000266	0.00552	CbGpPWpGaD
Dabrafenib—RAF1—Insulin receptor signalling cascade—FGF2—gestational diabetes	0.00026	0.00541	CbGpPWpGaD
Dabrafenib—RAF1—IGF1R signaling cascade—FGF2—gestational diabetes	0.00026	0.00541	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—LEP—gestational diabetes	0.000258	0.00536	CbGpPWpGaD
Dabrafenib—BRAF—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000256	0.00531	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000248	0.00515	CbGpPWpGaD
Dabrafenib—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000248	0.00515	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—FGF2—gestational diabetes	0.000239	0.00497	CbGpPWpGaD
Dabrafenib—RAF1—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.000239	0.00497	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000223	0.00463	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Insulin receptor—FGF2—gestational diabetes	0.000216	0.00449	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000211	0.00438	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000208	0.00432	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000207	0.00429	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GGCT—gestational diabetes	0.000205	0.00425	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.0002	0.00416	CbGpPWpGaD
Dabrafenib—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000198	0.00411	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000197	0.0041	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—FGF2—gestational diabetes	0.000196	0.00407	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000185	0.00384	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000184	0.00382	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GLS2—gestational diabetes	0.000179	0.00371	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000177	0.00368	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000177	0.00368	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—GCK—gestational diabetes	0.000175	0.00363	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—FGF2—gestational diabetes	0.000174	0.00362	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—FGF2—gestational diabetes	0.000173	0.0036	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—MBL2—gestational diabetes	0.000172	0.00356	CbGpPWpGaD
Dabrafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.00017	0.00354	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—FGF2—gestational diabetes	0.000166	0.00345	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—FGF2—gestational diabetes	0.000166	0.00344	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—FGF2—gestational diabetes	0.000165	0.00342	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—FGF2—gestational diabetes	0.000164	0.0034	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000162	0.00337	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.000161	0.00334	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00016	0.00332	CbGpPWpGaD
Dabrafenib—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000158	0.00329	CbGpPWpGaD
Dabrafenib—RAF1—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000158	0.00329	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—FGF2—gestational diabetes	0.000154	0.0032	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000154	0.0032	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000154	0.0032	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000153	0.00319	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—FGF2—gestational diabetes	0.000153	0.00317	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—FGF2—gestational diabetes	0.000152	0.00315	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000151	0.00315	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—FGF2—gestational diabetes	0.000151	0.00313	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000148	0.00308	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000145	0.00301	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—ADIPOQ—gestational diabetes	0.000144	0.00299	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—TNF—gestational diabetes	0.000141	0.00294	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.00014	0.0029	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GGCT—gestational diabetes	0.000137	0.00285	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000137	0.00284	CbGpPWpGaD
Dabrafenib—BRAF—Disease—RBP4—gestational diabetes	0.000134	0.00279	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000129	0.00269	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GGCT—gestational diabetes	0.000127	0.00264	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000125	0.0026	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LEPR—gestational diabetes	0.000122	0.00254	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NAMPT—gestational diabetes	0.000121	0.0025	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GLS2—gestational diabetes	0.00012	0.00249	CbGpPWpGaD
Dabrafenib—BRAF—Disease—GCK—gestational diabetes	0.00012	0.00249	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—TNF—gestational diabetes	0.000119	0.00248	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000113	0.00235	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GLS2—gestational diabetes	0.000111	0.00231	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000107	0.00223	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—FGF2—gestational diabetes	0.000105	0.00218	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—FGF2—gestational diabetes	0.000101	0.0021	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MBL2—gestational diabetes	9.99e-05	0.00208	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—NAMPT—gestational diabetes	9.8e-05	0.00203	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TNF—gestational diabetes	9.79e-05	0.00203	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GCK—gestational diabetes	9.74e-05	0.00202	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MTNR1B—gestational diabetes	9.66e-05	0.00201	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RBP4—gestational diabetes	9.42e-05	0.00196	CbGpPWpGaD
Dabrafenib—RAF1—Disease—RBP4—gestational diabetes	9.3e-05	0.00193	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—LEP—gestational diabetes	8.93e-05	0.00185	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	8.83e-05	0.00183	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	8.63e-05	0.00179	CbGpPWpGaD
Dabrafenib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	8.51e-05	0.00177	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LEPR—gestational diabetes	8.46e-05	0.00176	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—TNF—gestational diabetes	8.44e-05	0.00175	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NAMPT—gestational diabetes	8.34e-05	0.00173	CbGpPWpGaD
Dabrafenib—RAF1—Disease—GCK—gestational diabetes	8.29e-05	0.00172	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GGCT—gestational diabetes	7.9e-05	0.00164	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CYP19A1—gestational diabetes	7.12e-05	0.00148	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	6.99e-05	0.00145	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GLS2—gestational diabetes	6.9e-05	0.00143	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GGCT—gestational diabetes	6.88e-05	0.00143	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	6.84e-05	0.00142	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—FGF2—gestational diabetes	6.78e-05	0.00141	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MTNR1B—gestational diabetes	6.68e-05	0.00139	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NAMPT—gestational diabetes	6.58e-05	0.00137	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GCK—gestational diabetes	6.54e-05	0.00136	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RBP4—gestational diabetes	6.51e-05	0.00135	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	6.17e-05	0.00128	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NAMPT—gestational diabetes	6.09e-05	0.00127	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GCK—gestational diabetes	6.06e-05	0.00126	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GLS2—gestational diabetes	6.01e-05	0.00125	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—FGF2—gestational diabetes	5.99e-05	0.00124	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—FGF2—gestational diabetes	5.75e-05	0.00119	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CYP19A1—gestational diabetes	4.78e-05	0.000993	CbGpPWpGaD
Dabrafenib—BRAF—Disease—FGF2—gestational diabetes	4.66e-05	0.000967	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CYP19A1—gestational diabetes	4.43e-05	0.00092	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LEP—gestational diabetes	4.29e-05	0.000892	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GGCT—gestational diabetes	4.24e-05	0.00088	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	4.17e-05	0.000865	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TNF—gestational diabetes	4.13e-05	0.000858	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NAMPT—gestational diabetes	3.78e-05	0.000786	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GCK—gestational diabetes	3.76e-05	0.000781	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GLS2—gestational diabetes	3.71e-05	0.00077	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FGF2—gestational diabetes	3.49e-05	0.000725	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NAMPT—gestational diabetes	3.3e-05	0.000684	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GCK—gestational diabetes	3.27e-05	0.00068	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—FGF2—gestational diabetes	3.26e-05	0.000677	CbGpPWpGaD
Dabrafenib—RAF1—Disease—FGF2—gestational diabetes	3.22e-05	0.000669	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LEP—gestational diabetes	2.97e-05	0.000617	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP19A1—gestational diabetes	2.75e-05	0.000571	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.39e-05	0.000497	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FGF2—gestational diabetes	2.26e-05	0.000469	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NAMPT—gestational diabetes	2.03e-05	0.000422	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GCK—gestational diabetes	2.02e-05	0.000419	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.48e-05	0.000306	CbGpPWpGaD
